ASX-Listed Aroa Biosurgery climbs on higher annual revenue

Aroa Biosurgery

26/04/2022 07:01

** Shares of Aroa Biosurgery  ARX.AX  rise as much as 5.1%
to A$0.92, highest since Feb. 11
    ** New Zealand-based soft tissue repair company posts prelim
unaudited total revenue of NZ$39.7 mln ($26.37 mln) for FY22, up
78%  urn:newsml:reuters.com:*:nFWN2WN1AX
    ** Company says its prelim unaudited FY22 product revenue
rose 84% to NZ$39.2 mln 
    ** Stock down 14.2% this year, as of last close
    
 ($1 = 1.5056 New Zealand dollars)

 (Reporting by Navya Mittal in Bengaluru)
 ((navya.mittal@thomsonreuters.com))